Abstract
Demyelination and axonal loss have been described as the histological hallmarks of inflammatory lesions of multiple sclerosis (MS) and are the pathological correlates of persistent disability. However, the immune mechanisms underlying axonal damage in MS remain unknown. Here, we report the use of single chain-variable domain fragments (scFv) from clonally expanded cerebrospinal fluid (CSF) B cells to show the role of an anti-axon immune response in the central nervous system (CNS) in MS. The cellular and subcellular distribution of the antigen(s) recognized by these CSF-derived clonal scFv antibodies (CSFC-scFv Abs) was studied by immunochemical staining of brain tissues obtained at autopsy from patients with MS. Immunochemistry showed specific binding of CSFC-scFv Abs to axons in acute MS lesions. The stained axons showed three major types of axonal pathological changes: 1) linear axons, axonal ovoid formation, and axonal transection were seen in the myelinated white matter adjacent to the lesion; 2) accumulation of axonal ovoid formations and Wallerian degeneration were seen at the border between demyelinated lesions and the adjacent white matter; and 3) Wallerian degeneration occurred at the center and edge of acute demyelinated lesions. These findings suggest a B cell axonal specific immune response in the CNS in MS.
Article PDF
Similar content being viewed by others
References
Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H: Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann Neurol 47:707–717, 2000
Compston A, Coles A: Multiple sclerosis. Lancet 359:1221–1231, 2002
Robinson WH, DiGennaro C, Hueber W, Haab BB, Kamachi M, Dean EJ, Fournel S, Fong D, Genovese MC, de Vegvar HE, Skriner K, Hirschberg DL, Morris RI, Muller S, Pruijn GJ, van Venrooij WJ, Smolen JS, Brown PO, Steinman L, Utz PJ: Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med 8:295–301, 2002
Chabas D, Baranzini SE, Mitchell D, Bernard CC, Rittling SR, Denhardt DT, Sobel RA, Lock C, Karpuj M, Pedotti R, Heller R, Oksenberg JR, Steinman L: The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294:1731–1735, 2001
Ben-Nun A, Wekerle H, Cohen IR: Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein. Nature 292:60–61, 1981
Schluesener HJ, Lider O, Sobel RA: Induction of hyperacute brain inflammation and demyelination by activated encephalitogenic T cells and a monoclonal antibody specific for a myelin/oligodendrocyte glycoprotein. Autoimmunity 2:265–273, 1989
Itoyama Y, Webster HD: Immunocytochemical study of myelin-associated glycoprotein (MAG) and basic protein (BP) in acute experimental allergic encephalomyelitis (EAE). J Neuroimmunol 3:351–364, 1982
Tourtellotte W: On cerebrospinal fluid immunoglobulin-G (IgG) quotients in multiple sclerosis and other diseases. A review and a new formula to estimate the amount of IgG synthesized per day by the central nervous system. J Neurol Sci 10:279–304, 970
Tibbling G, Link H, Ohman S: Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest 37:385–390, 1977
Esiri MM: Immunoglobulin-containing cells in multiple-sclerosis plaques. Lancet 2:478, 1977
Qin Y, Duquette P, Zhang Y, Talbot P, Poole R, Antel J: Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis. J Clin Invest 102:1045–1050, 1998
Owens GP, Kraus H, Burgoon MP, Smith-Jensen T, Devlin ME, Gilden DH: Restricted use of VH4 germline segments in an acute multiple sclerosis brain. Ann Neurol 43:236–243, 1998
Qin Y, Duquette P, Zhang Y, Olek M, Da RR, Richardson J, Antel JP, Talbot P, Cashman NR, Tourtellotte WW, Wekerle H, Van Den Noort S: Intrathecal B-cell clonal expansion, an early sign of humoral immunity, in the cerebrospinal fluid of patients with clinically isolated syndrome suggestive of multiple sclerosis. Lab Invest 83:1081–1088, 2003
Baranzini SE, Jeong MC, Butunoi C, Murray RS, Bernard CC, Oksenberg JR: B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions. J Immunol 163:5133–5144, 1999
Colombo M, Dono M, Gazzola P, Roncella S, Valetto A, Chiorazzi N, Mancardi GL, Ferrarini M: Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients. J Immunol 164:2782–2789, 2000
Ritchie AM, Gilden DH, Williamson RA, Burgoon MP, Yu X, Helm K, Corboy JR, Owens GP: Comparative analysis of the CD19+ and CD138+ cell antibody repertoires in the cerebrospinal fluid of patients with multiple sclerosis. J Immunol 173:649–656, 2004
Owens GP, Ritchie AM, Burgoon MP, Williamson RA, Corboy JR, Gilden DH: Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid. J Immunol 171:2725–2733, 2003
Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA: Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487–491, 1988
Welschof M, Terness P, Kolbinger F, Zewe M, Dubel S, Dorsam H, Hain C, Finger M, Jung M, Moldenhauer G, et al.: Amino acid sequence based PCR primers for amplification of rearranged human heavy and light chain immunoglobulin variable region genes. J Immunol Methods 179:203–214, 1995
Hanahan D: Techniques for transformation of E. coli. Washington DC, IRL, 1985, p 109
Tsumoto K, Nishimiya Y, Kasai N, Ueda H, Nagamune T, Ogasahara K, Yutani K, Tokuhisa K, Matsushima M, Kumagai I: Novel selection method for engineered antibodies using the mechanism of Fv fragment stabilization in the presence of antigen. Protein Eng 10:1311–1318, 1997
Shamsuddin AM, Harris CC: Improved enzyme immunoassays using biotin-avidin-enzyme complex. Arch Pathol Lab Med 107:514–517, 1983
Suzuki K, Andrews JM, Waltz JM, Terry RD: Ultrastructural studies of multiple sclerosis. Lab Invest 20:444–454, 1969
Ikuta F, Zimmerman HM: Distribution of plaques in seventy autopsy cases of multiple sclerosis in the United States. Neurology 26:26–28, 1976
Kornek B, Lassmann H: Axonal pathology in multiple sclerosis. A historical note. Brain Pathol 9:651–656, 1999
Matthews PM, De Stefano N, Narayanan S, Francis GS, Wolinsky JS, Antel JP, Arnold DL: Putting magnetic resonance spectroscopy studies in context: Axonal damage and disability in multiple sclerosis. Semin Neurol 18:327–336, 1998
Grimaud J, Barker GJ, Wang L, Lai M, MacManus DG, Webb SL, Thompson AJ, McDonald WI, Tofts PS, Miller DH: Correlation of magnetic resonance imaging parameters with clinical disability in multiple sclerosis: A preliminary study. J Neurol 246:961–967, 1999
Fisher E, Rudick RA, Cutter G, Baier M, Miller D, Weinstock-Guttman B, Mass MK, Dougherty DS, Simonian NA: Relationship between brain atrophy and disability: An 8-year follow-up study of multiple sclerosis patients. Mult Scler 6:373–377, 2000
Paolillo A, Pozzilli C, Gasperini C, Giugni E, Mainero C, Giuliani S, Tomassini V, Millefiorini E, Bastianello S: Brain atrophy in relapsing-remitting multiple sclerosis: Relationship with ‘black holes,’ disease duration and clinical disability. J Neurol Sci 174:85–91, 2000
Pelletier J, Suchet L, Witjas T, Habib M, Guttmann CR, Salamon G, Lyon-Caen O, Cherif AA: A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis. Arch Neurol 58:105–111, 2001
MacLennan IC, Gray D: Antigen-driven selection of virgin and memory B cells. Immunol Rev 91:61–85, 1986
Berek C, Jarvis JM, Milstein C: Activation of memory and virgin B cell clones in hyperimmune animals. Eur J Immunol 17:1121–1129, 1987
Gray D, Skarvall H: B-cell memory is short-lived in the absence of antigen. Nature 336:70–73, 1988
Jacob J, Kelsoe G: In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. II. A common clonal origin for periarteriolar lymphoid sheath-associated foci and germinal centers. J Exp Med 176:679–687, 1992
Liu YJ, Johnson GD, Gordon J, MacLennan IC: Germinal centres in T-cell-dependent antibody responses. Immunol Today 13:17–21, 1992
Siekevitz M, Kocks C, Rajewsky K, Dildrop R: Analysis of somatic mutation and class switching in naive and memory B cells generating adoptive primary and secondary responses. Cell 48:757–770, 1987
Zhang M, Majid A, Bardwell P, Vee C, Davidson A: Rheumatoid factor specificity of a VH3-encoded antibody is dependent on the heavy chain CDR3 region and is independent of protein A binding. J Immunol 161:2284–2289, 1998
Jukes TH, King JL: Evolutionary nucleotide replacements in DNA. Nature 281:605–606, 1979
Barrios Y, Jirholt P, Ohlin M: Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor. J Mol Recognit 17:332–338, 2004
Olsen RJ, Mazlo J, Koepsell SA, McKeithan TW, Hinrichs SH: Minimal structural elements of an inhibitory anti-ATF1/CREB single-chain antibody fragment (scFv41.4). Hybrid Hybridomics 22:65–77, 2003
Nashmi R, Fehlings MG: Changes in axonal physiology and morphology after chronic compressive injury of the rat thoracic spinal cord. Neuroscience 104:235–251, 2001
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, Y., Da, RR., Guo, W. et al. Axon Reactive B Cells Clonally Expanded in the Cerebrospinal Fluid of Patients with Multiple Sclerosis. J Clin Immunol 25, 254–264 (2005). https://doi.org/10.1007/s10875-005-4083-5
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10875-005-4083-5